Amjevita Injection
RxNorm Crosswalk NDC 55513-413

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Amjevita (NDC 55513-413) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 18 unique RxNorm concepts. By anchoring Amgen, Inc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe
(RxCUI 2627711)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 20 MG in 0.4 ML Prefilled Syringe
(RxCUI 2627717)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.8 ML adalimumab-atto 50 MG/ML Auto-Injector
(RxCUI 2627719)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 40 MG in 0.8 ML Auto-Injector
(RxCUI 2627722)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.8 ML adalimumab-atto 50 MG/ML Prefilled Syringe
(RxCUI 2627724)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 40 MG in 0.8 ML Prefilled Syringe
(RxCUI 2627725)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe
(RxCUI 2634478)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 10 MG in 0.2 ML Prefilled Syringe
(RxCUI 2634479)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.2 ML adalimumab-atto 100 MG/ML Prefilled Syringe
(RxCUI 2663901)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 20 MG in 0.2 ML Prefilled Syringe
(RxCUI 2663904)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.4 ML adalimumab-atto 100 MG/ML Prefilled Syringe
(RxCUI 2663906)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 40 MG in 0.4 ML Prefilled Syringe
(RxCUI 2663907)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.4 ML adalimumab-atto 100 MG/ML Auto-Injector
(RxCUI 2663908)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 40 MG in 0.4 ML Auto-Injector
(RxCUI 2663910)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.8 ML adalimumab-atto 100 MG/ML Prefilled Syringe
(RxCUI 2663912)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 80 MG in 0.8 ML Prefilled Syringe
(RxCUI 2663913)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

0.8 ML adalimumab-atto 100 MG/ML Auto-Injector
(RxCUI 2663914)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

AMJEVITA 80 MG in 0.8 ML Auto-Injector
(RxCUI 2663915)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Amjevita

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 55513-413 to RxCUI 2627711, 2627717, 2627719, 2627722, 2627724, 2627725, 2634478, 2634479, 2663901, 2663904, 2663906, 2663907, 2663908, 2663910, 2663912, 2663913, 2663914, 2663915, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.